NCT01064492View on ClinicalTrials.gov

A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Healthy Volunteers

Interventions

DRUG

PF-04620110

The three treatments are A) a single dose of 5 mg PIC under fasted condition; B) a single dose of 5 mg tablet under fasted condition: and C) a single dose of 5 mg tablet under fed condition.

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels